North America Is Expected To Hold A Dominant Position In The Global Digital Medicine Market And This Is Attributed To The High Burden Of Chronic Disease
The global digital medicine market is expected to witness strong growth on the account of the high usage of smartphones around the globe. Rapidly growing mobile technology due to growing use of mobile device across health care settings which is driving demand for development of medical software applications (apps) for these platforms. According to Pew Research Center 2019 data, mobile technology has expanded rapidly around the globe. Its estimate that more than 5 billion people have smartphones globally. Moreover, the growing popularity of personalized medicine is further anticipated to foster the growth of the digital medicine market. According to Dosis Personalized and Digital Medicine Consumer Report surveyed in 2019 more than 1,000 consumers, weighted for the U.S. population, to gain a better understanding between the advances in personalized medicine approaches and general consumer awareness of its benefits.
North America is expected to hold a dominant position in the global digital medicine market and this is attributed to the high burden of chronic disease in the region. According to the National Health Council, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions.
1. In November 2020, MindMed a psychedelic medicine biotech company has developed a digital medicine division known as Albert. Albert will help in the process of assembling and recruiting a team of technologists, therapists, and clinical drug development experts to help the company research, develop and build an integrated technology platform and comprehensive toolset.
2. In June 2020, Pharma cos launch Pharma App to market products and educate doctors about new drugs in the wake of the lockdown crisis
3. In June 2020, Infosys a global provider of next-generation digital services and consulting announced the launch of an all-new, Personalized Medicine solution for the pharmaceutical industry.
4. In September 2020, The U.S. Food and Drug Administration announced the launch of the Digital Health Center of Excellence within the Center for Devices and Radiological Health (CDRH).
Within the medical field of digital medicine, digital medicines are a new class of pharmaceuticals that combines an ingested data element with a prescription drug. For example, rather than needing to write a prescription for heart medication and then go to the pharmacy to pick it up, one can simply take an insulin shot every day. Digital technologies and devices are making it much easier for individuals to obtain healthcare information and for healthcare professionals to provide personalized care to their patients.

Comments
Post a Comment